These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17722528)

  • 1. Chitosan nanoparticles for oral drug and gene delivery.
    Bowman K; Leong KW
    Int J Nanomedicine; 2006; 1(2):117-28. PubMed ID: 17722528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
    Takeuchi I; Takeshita T; Suzuki T; Makino K
    Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
    Pontillo ARN; Detsi A
    Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats.
    Shailender J; Ravi PR; Reddy Sirukuri M; Dalvi A; Keerthi Priya O
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1109-1119. PubMed ID: 29409342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
    Tsai LC; Chen CH; Lin CW; Ho YC; Mi FL
    Int J Biol Macromol; 2019 Apr; 126():141-150. PubMed ID: 30586591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
    Phukan K; Nandy M; Sharma RB; Sharma HK
    Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Important Polysaccharides as Carriers for Drug Delivery.
    Huang G; Chen Y; Li Y; Huang D; Han J; Yang M
    Mini Rev Med Chem; 2015; 15(13):1103-9. PubMed ID: 26156418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery.
    Bhattarai N; Ramay HR; Chou SH; Zhang M
    Int J Nanomedicine; 2006; 1(2):181-7. PubMed ID: 17722534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
    Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
    Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
    Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles: crossing barriers and membrane interactions.
    Puri A
    Mol Membr Biol; 2010 Oct; 27(7):213-4. PubMed ID: 20929338
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin.
    Khdair A; Hamad I; Alkhatib H; Bustanji Y; Mohammad M; Tayem R; Aiedeh K
    Eur J Pharm Sci; 2016 Oct; 93():38-44. PubMed ID: 27473308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for Intranasal Delivery to Improve Brain Uptake.
    Patel AA; Patel RJ; Patel SR
    Curr Drug Deliv; 2018; 15(4):461-469. PubMed ID: 29034836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
    Rao S; Prestidge CA
    Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
    Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
    Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.